Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Enveric Biosciences, Inc. - Common Stock
(NQ:
ENVB
)
5.900
+0.080 (+1.37%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enveric Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates
November 26, 2025
From
Enveric Biosciences
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
November 19, 2025
Via
Benzinga
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results
November 14, 2025
From
Enveric Biosciences
Via
Business Wire
Which stocks are moving on Monday?
↗
November 03, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Enveric Biosciences Announces Reverse Stock Split
October 23, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance
October 16, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal
October 15, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences to Explore Digital Asset Treasury Opportunities
October 14, 2025
From
Enveric Biosciences
Via
Business Wire
These stocks are gapping in today's session
↗
October 03, 2025
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.
Via
Chartmill
These stocks that are showing activity before the opening bell on Friday.
↗
October 03, 2025
Wondering what's happening in Friday's pre-market session? Find an overview in this article.
Via
Chartmill
Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials
October 02, 2025
From
Enveric Biosciences
Via
Business Wire
Stay updated with the stocks that are on the move in today's pre-market session.
↗
September 30, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 29, 2025
Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market session. The company's market cap stands at $2.2 million.
Via
Benzinga
Stay updated with the stocks that are on the move in today's after-hours session.
↗
September 29, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
September 18, 2025
From
Enveric Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
September 17, 2025
Via
Benzinga
Which stocks are experiencing notable movement on Wednesday?
↗
September 17, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Wednesday's session: gap up and gap down stocks
↗
September 17, 2025
Let's delve into the US markets on Wednesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via
Chartmill
Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds
September 17, 2025
From
Enveric Biosciences, Inc.
Via
Business Wire
Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery
September 17, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission
September 16, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference
September 03, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA
September 02, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications
August 28, 2025
From
Enveric Biosciences, Inc.
Via
Business Wire
Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results
August 14, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series
July 23, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)
July 15, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003
June 24, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Announces Participation in 2025 BIO International Convention
June 16, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders
June 10, 2025
From
Enveric Biosciences
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
